Q2 2024 · 13F-HR
Integral Health Asset Management, LLCholdings as filed
Filed 2024-08-14 · accession 0001172661-24-003360
$1.05B
Reported value
72
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 457669307 | INSM | INSMED INC | $103.8M | 9.87% | 1,550,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $66.5M | 6.32% | 500,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $54.2M | 5.15% | 1,000,000 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $50.1M | 4.76% | 650,000 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $43.3M | 4.12% | 80,000 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $36.6M | 3.48% | 340,000 | Common | SOLE |
| 66987V109 | NVS | NOVARTIS AG | $31.9M | 3.03% | 300,000 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $29.7M | 2.82% | 1,100,000 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $29.1M | 2.76% | 235,000 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $28.0M | 2.66% | 75,000 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $25.7M | 2.44% | 300,000 | Common | SOLE |
| 913903100 | UHS | UNIVERSAL HLTH SVCS INC | $24.0M | 2.28% | 130,000 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $23.8M | 2.26% | 500,000 | CALL | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $19.3M | 1.83% | 400,000 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $18.1M | 1.72% | 500,000 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $17.9M | 1.70% | 400,000 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $17.5M | 1.67% | 75,000 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $16.5M | 1.57% | 50,000 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $16.0M | 1.52% | 590,000 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $15.6M | 1.48% | 85,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $15.2M | 1.44% | 275,000 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $14.1M | 1.34% | 45,000 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $13.9M | 1.32% | 150,000 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $13.8M | 1.31% | 25,000 | Common | SOLE |
| 74834L100 | DGX | QUEST DIAGNOSTICS INC | $13.7M | 1.30% | 100,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $13.3M | 1.26% | 250,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $13.3M | 1.26% | 250,000 | CALL | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $12.6M | 1.20% | 325,000 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $12.5M | 1.19% | 40,000 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $11.9M | 1.13% | 250,000 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $11.7M | 1.11% | 20,000 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $11.1M | 1.06% | 950,000 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $10.9M | 1.03% | 400,000 | PUT | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $9.9M | 0.94% | 145,000 | Common | SOLE |
| 80105N105 | SNY | SANOFI | $9.7M | 0.92% | 200,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $9.7M | 0.92% | 220,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $9.6M | 0.92% | 70,000 | Common | SOLE |
| 879369106 | TFX | TELEFLEX INCORPORATED | $9.5M | 0.90% | 45,000 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $9.1M | 0.86% | 10,000 | Common | SOLE |
| 379577208 | GMED | GLOBUS MED INC | $8.6M | 0.81% | 125,000 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $8.3M | 0.79% | 130,000 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $8.1M | 0.77% | 150,000 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $7.9M | 0.75% | 500,000 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $7.6M | 0.72% | 60,000 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $7.5M | 0.72% | 325,000 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $7.2M | 0.68% | 2,325,000 | Common | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $6.6M | 0.62% | 1,200,000 | Common | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $6.5M | 0.62% | 450,000 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $6.4M | 0.61% | 1,775,000 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $5.9M | 0.56% | 100,000 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $5.0M | 0.48% | 25,000 | Common | SOLE |
| 219798105 | QDEL | QUIDELORTHO CORP | $5.0M | 0.47% | 150,000 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $4.9M | 0.46% | 750,000 | Common | SOLE |
| 86881A100 | SGRY | SURGERY PARTNERS INC | $4.8M | 0.45% | 200,000 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $4.5M | 0.43% | 100,000 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $4.4M | 0.42% | 10,000 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $4.3M | 0.40% | 275,000 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $4.2M | 0.40% | 400,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $3.9M | 0.37% | 85,000 | Common | SOLE |
| 436440101 | HO1 | HOLOGIC INC | $3.7M | 0.35% | 50,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $3.6M | 0.34% | 450,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $3.5M | 0.34% | 100,000 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $3.3M | 0.32% | 400,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $3.2M | 0.30% | 425,000 | Common | SOLE |
| 28106W103 | EDIT | EDITAS MEDICINE INC | $3.2M | 0.30% | 675,000 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $3.1M | 0.30% | 80,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $3.1M | 0.30% | 150,000 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $2.8M | 0.26% | 850,000 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $2.5M | 0.24% | 70,000 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $2.4M | 0.22% | 100,000 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $2.1M | 0.20% | 100,000 | Common | SOLE |
| 761330109 | RVNCEUR | REVANCE THERAPEUTICS INC | $1.3M | 0.12% | 500,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.